6 results
Table of Common Rate Control Agents via AHA/ACC/HRS Guidelines #Management #Pharm #EM #IM #Cardiology #Afib #Common
Table of Common ... Agents via AHA/ACC ... HRS Guidelines #Management ... #Pharm #EM #IM ... #Cardiology #Afib
Cardiac Valve Replacement - Anticoagulation INR Targets and Antiplatelet by Valve Type

Bioprosthetic valves require at least
Replacement - Anticoagulation ... monotherapy (2017 AHA/ACC ... valve (2017 AHA/ACC ... #Management #Cardiology ... #Target #DOAC #Table
Anticoagulant Therapy after PCI (patients with AFib)
Dual-Therapy Preferred:
 • Triple therapy = increased bleeding
(patients with AFib ... - Bleeding risk ... derick_gabel via ACCP Cardiology ... Triple #therapy #anticoagulation ... #management #cardiology
Atrial Fibrillation (A-Fib) Summary

Symptoms:
• Palpitations, light-headedness, dizziness, dyspnea, exercise intolerance, chest pain, near-syncope, syncope.

Why?
Cardiac:
	• Valvular heart
control with early Afib ... cardiovascular risk ... #Fibrillation #AFib ... #diagnosis #management ... #cardiology
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
event, follow ACC ... Stable patients ... Anticoagulation ... one post op Cardiology ... medical and surgical management
Peripartum Cardiomyopathy - Summary
1. Definition
 • Towards the end of pregnancy to 5 months postpartum
Risk Factors and ... Management during ... Delivery • Stable ... suggest prophylactic anticoagulation ... #cardiology #treatment